home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

2-day In-person Seminar on why is FDA at my Facility, and what do I do During an Inspection at Los Angeles, CA

 
  November 23, 2013  
     
 


GlobalCompliancePanel, DoubleTree by Hilton Hotel Los Angeles Downtown, 120 South Los Angeles Street, Los Angeles, California, 90012, USA
2013-12-05


Overview:

Many regulated companies preparing for FDA inspections are not prepared and the outcome can be negative as we see all the time with enforcement actions. This seminar provides the fundamentals and the ground rules on how to prepare for and survive an FDA inspection no matter if you are a Class I, II, III device or a pharmaceutical or biologics manufacturer. This presentation will review and emphasize the do's and don'ts and cardinal rules as to interviewing, how to respond, reviewing documentation, etiquette, use of certain words, body language, responding to questions/requests, etc., and certainly replying to 483's and Warning Letters. Emphasis is placed on the company's SOP on dealing with inspectors and knowing how to be prepared, proactive...and being able to defend and justify... and what it takes to achieve a favorable outcome. This seminar provides background and understanding of the role played by the Agency, its administrative and enforcement powers. It takes the participant step by step through the entire inspection process and describes various types of inspections.

Day 1 – Agenda

Lecture 1: How a firm should prepare for an FDA inspection 

Lecture 2: Ways to train employees in view of the inspection 

Lecture 3: How to ensure that required documentation is in place 

Lecture 4: How to interact with the investigator-DO's and DON'T's 

Lecture 5: What companies should do when the inspection ends 

Lecture 6: How to reply to 483's and warning letters 

Lecture 7: Legal implications of non-compliance 

Lecture 8: Post inspection actions

Day 2 – Agenda

Lecture 1: Why inspections are conducted and by what statutory authority         

Lecture 2: The emphasis on systems-based inspections...and the IOM and other crucial FDA reference documents

 

Lecture 3: What is subject to FDA purview and what's off-limits

 

Lecture 4: Understand and apply the do's and don'ts and comprehend that preparation is the key to success

 

Lecture 5: What are the prohibited "Acts" and the enforcement categories that you need to deal with

 

Lecture 6: What you need to know and do to prepare for, during and even after the inspection...and why your inspection response team is key

 

Lecture 7: the Company’s Inspection Plan (SOP) can make or break the inspection depending on how to use it and training your personnel

 

Lecture 8: How to respond to findings and facilitating the documentation and remediation process...and reaching final closure

 

Lecture 9: Define clear responsibilities, roles and goals for personnel involved in SOP development

Who Will Benefit:

FDA regulated Industries

Dietary Supplements

Healthcare IT

Top and Middle Management

Quality Assurance/Management

Compliance Management

Manufacturing

Laboratory

Regulatory Affairs

Information Technology

Marketing & Sales

Laboratories

Manufacturing facilities

DATE, VENUE & PRICE:

Location: Los Angeles, CA | 5th & 6th December 2013 | 9 AM to 6 PM

Venue: DoubleTree by Hilton Hotel Los Angeles Downtown

Price: $1,295.00 

Register now and save $200. (Early Bird)

Until November 10, Early Bird Price: $1,295.00

From November 11 to December 03, Regular Price: $1,495.00

 

 
 
Organized by: GlobalCompliancePanel
Invited Speakers:

David R. Dills, Regulatory & Compliance Consultant with more than 24 years of hands-on experience and a proven track record within the FDA regulated industry, has an extensive regulatory and compliance background with Class I/II/III and IVD devices, pharmaceutical operations, and manages activities within the global regulatory and compliance space. He manages quality, regulatory and compliance projects with multiple competing priorities having a direct impact on site operations and commercial opportunities and develops strategies for governmental approval to introduce new products to market, provides guidance on regulatory and compliance requirements and prepares/reviews worldwide submissions/dossiers/technical files and addresses global regulatory requirements.

 

Register Now 

 
Deadline for Abstracts: 2013-12-05
 
Registration:

Contact Information: 

Event Coordinator

Toll free: 1800 447 9407
Fax: 302 288 6884

Email: support@globalcompliancepanel.com

Website: https://www.globalcompliancepanel.com

LIVE CHAT SUPPORT ALSO - http://www.globalcompliancepanel.com/chat/client.php

Net Zealous LLC,

DBA GlobalCompliancePanel,

161 Mission Falls Lane,

Suite 216, Fremont, CA 94539, USA 

Register Now  

E-mail: support@globalcompliancepanel.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.